The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Self-citationGrivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationThe inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationWaage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040 · cited 1×
“The soluble IL-6R: a buffer in the blood In healthy individuals levels of IL-6 in the plasma are extremely low, close to the detection limit of 1 pg/ml [23].”
BackgroundSelf-citationINTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
Wang, R.-X., Yu, C.-R., Dambuza, I. M., Mahdi, R. M., Dolinska, M. B., Sergeev, Y. V., Wingfield, P. T., Kim, S.-H., & Egwuagu, C. E. (2014) · Nature Medicine · doi:10.1038/nm.3554 · Cited by 733
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationTherapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Self-citationSoluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationInterleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618
Self-citationThe composition and signaling of the IL-35 receptor are unconventional
Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2227 · Cited by 450
Versatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 407
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
Self-citationAnti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
Taylor, P. C., & Feldmann, M. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.181 · Cited by 389
IL-6 biology: implications for clinical targeting in rheumatic disease
Calabrese, L. H., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 328
Self-citationFerreira, R. C., Freitag, D. F., Cutler, A. J., Howson, J. M. M., Rainbow, D. B., Smyth, D. J., Kaptoge, S., Clarke, P., Boreham, C., Coulson, R. M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003444 · Cited by 316
Harker, J. A., Lewis, G. M., Mack, L., & Zuniga, E. I. (2011) · Science · doi:10.1126/science.1208421 · Cited by 311
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities
Scheller, J., Garbers, C., & Rose-John, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.002 · Cited by 308
Self-citationThe soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., & Scheller, J. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.007 · Cited by 289
Self-citationIL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality
Zhang, H., Neuhöfer, P., Song, L., Rabe, B., Lesina, M., Kurkowski, M. U., Treiber, M., Wartmann, T., Regnér, S., Thorlacius, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64931 · Cited by 288
Self-citationNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationTherapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., & Garcia, K. C. (2001) · Science · doi:10.1126/science.1058308 · Cited by 261
Self-citationTrans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Campbell, I. L., Erta, M., Lim, S. L., Frausto, R., May, U., Rose-John, S., Scheller, J., & Hidalgo, J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-13.2014 · Cited by 247
Self-citationTransgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Self-citationTranssignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229435 · Cited by 243
Self-citationInhibition of IL-6 family cytokines by SOCS3
Babon, J. J., Varghese, L. N., & Nicola, N. A. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.12.004 · Cited by 216
Matsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Self-citationA role for IL-27p28 as an antagonist of gp130-mediated signaling
Stumhofer, J. S., Tait, E. D., III, W. J. Q., Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1957 · Cited by 184
Self-citationIL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 170
Self-citationBarkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169
Self-citationGarbers, C., Monhasery, N., Aparicio-Siegmund, S., Lokau, J., Baran, P., Nowell, M. A., Jones, S. A., Rose-John, S., & Scheller, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.018 · Cited by 155
Self-citationCrabé, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Bigouagou, U. M., Lefouili, F., Cognet, I., Ferlin, W. G., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901464 · Cited by 150
Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited
Schuster, B., Kovaleva, M., Sun, Y. E., Regenhard, P., Matthews, V. B., Grötzinger, J., Rose‐John, S., & Kallen, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210044200 · Cited by 143
Self-citationFerraccioli, G., Bracci‐Laudiero, L., Alivernini, S., Gremese, E., Tolusso, B., & Benedetti, F. D. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00067 · Cited by 135
Garbers, C., Spudy, B., Aparicio-Siegmund, S., Waetzig, G. H., Sommer, J., Hölscher, C., Rose‐John, S., Grötzinger, J., Lorenzen, I., & Scheller, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432955 · Cited by 132
Self-citationSTAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose-John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 123
Self-citationThe IL-6 feed-forward loop: A driver of tumorigenesis
Chang, Q., Daly, L., & Bromberg, J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.007 · Cited by 108
IL-6 trans-signaling-dependent rapid development of cytotoxic CD8+ T cell function.
Böttcher, J. P., Schanz, O., Garbers, C., Zaremba, A., Hegenbarth, S., Kurts, C., Beyer, M., Schultze, J., Kastenmüller, W., Rose-John, S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.008 · Cited by 98
Self-citationWang, R., Yu, C., Mahdi, R. M., & Egwuagu, C. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390625 · Cited by 95
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose‐John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 93
Self-citationInflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
Luig, M., Kluger, M. A., Goerke, B., Meyer, M. C., Nosko, A., Yan, I., Scheller, J., Mittrücker, H., Rose‐John, S., Stahl, R. A. K., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060620 · Cited by 87
Self-citationHarker, J. A., Dolgoter, A., & Zúñiga, E. I. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.010 · Cited by 81
Sodenkamp, J., Waetzig, G. H., Scheller, J., Seegert, D., Grötzinger, J., Rose‐John, S., Ehlers, S., & Hölscher, C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.015 · Cited by 74
Self-citationNo inhibition of IL-27 signaling by soluble gp130
Scheller, J., Schuster, B., Hölscher, C., Yoshimoto, T., & Rose‐John, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.098 · Cited by 66
Self-citationPflanz, S., Tacken, I., Grötzinger, J., Jacques, Y., Dahmen, H., Heinrich, P. C., & Müller‐Newen, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00477-9 · Cited by 55
Dibra, D., Cutrera, J. J., Xia, X., Kallakury, B., Mishra, L., & Li, S. (2011) · Hepatology · doi:10.1002/hep.24814 · Cited by 52
Tormo, A. J., Meliani, Y., Beaupré, L. A., Sharma, M., Fritz, J. H., Elson, G., Crabé, S., & Gauchat, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201595 · Cited by 48
Aparicio-Siegmund, S., Sommer, J., Monhasery, N., Schwanbeck, R., Keil, E., Finkenstädt, D., Pfeffer, K., Rose‐John, S., Scheller, J., & Garbers, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1852 · Cited by 47
Self-citationSommer, J., Garbers, C., Wolf, J., Trad, A., Moll, J. M., Sack, M., Fischer, R., Grötzinger, J., Waetzig, G. H., Floss, D. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560938 · Cited by 45
Self-citationCutting Edge: Inhibition of IL-6 Trans-Signaling Protects from Malaria-Induced Lethality in Mice
Wunderlich, C. M., Delić, D., Behnke, K., Meryk, A., Ströhle, P., Chaurasia, B., Al‐Quraishy, S., Wunderlich, F. T., Brüning, J. C., & Wunderlich, F. T. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102137 · Cited by 45
Trp53 Deficiency Protects against Acute Intestinal Inflammation
Spehlmann, M. E., Manthey, C., Dann, S. M., Hanson, E. M., Sandhu, S. S., Liu, L. Y., Abdelmalak, F. K., Diamanti, M. A., Retzlaff, K., Scheller, J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201716 · Cited by 40
Self-citationGP130 activation induces myeloma and collaborates with MYC
Dechow, T. N., Steidle, S., Götze, K. S. S., Rudelius, M., Behnke, K., Pechloff, K., Kratzat, S., Bullinger, L., Fend, F., Soberon, V., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69094 · Cited by 37
Self-citationRecombinant p35 from Bacteria Can Form Interleukin (IL-)12, but Not IL-35
Aparicio-Siegmund, S., Moll, J. M., Lokau, J., Grusdat, M., Schröder, J., Philipp, S., Rose‐John, S., Grötzinger, J., Lang, P. A., Scheller, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107990 · Cited by 30
Self-citation
Cited by
Teachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102
Self-citationIL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Self-citationCosta, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
Role of STAT3 signaling pathway in breast cancer
Ma, J.-H., Qin, L., & Li, X. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0527-z · Cited by 420
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Qin, J.-J., Yan, L., Zhang, J., & Zhang, W.-D. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1206-z · Cited by 396
Metadata
- Authors
- Garbers, C., Aparicio-Siegmund, S., & Rose-John, S.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 34
- Pages
- 75-82
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W2040736784
- Cited by
- 429
- References
- 61
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.